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Sir: Recently Ciroldi et al. reported
on the ability of family members to
predict patient’s consent to critical
care research [1]. They showed that
family members designated to serve
as surrogate decision makers fail
to accurately consent to research in
one-third to one-half of cases.
We would like to recall a previous
report on the same topic. In 2005 we
asked representatives of 714 patients
to grade their competence in giving
surrogate informed consent for the
temporarily incapable patient, from
1 (“very incompetent”) to 10 (“very
competent”) [2]. This was done for
two hypothetical situations: (a) in the
case that a medical decision had to be
made (i.e., the performance of a sur-
gical procedure) and (b) in the event
that the patient was considered to be
a potential candidate to participate
in critical care research (i.e., partic-
ipation in a randomized controlled
trial comparing a new therapy with
standard care). If patients regained
competence before discharge from
the intensive care unit (ICU), they
were asked to grade their representa-
tive for the task of giving informed
consent in the same way. The most
important ﬁnding of this study was
that patients felt their surrogate de-
cision makers were very capable
of representing them in respect of
medical decisions as well as partic-
ipation in research [patients graded
their surrogate decision makers 8.0
(interquartile range 7.0–9.0) for both
decisions]; there was no signiﬁcant
difference in rating of the patients
for the different representatives
(spouses, parents, children, siblings,
and others). We also found that repre-
sentatives felt very conﬁdent in their
ability to represent the patients [they
graded themselves 8.0 (7.0–9.0)];
while there was a signiﬁcant differ-
ence in conﬁdence for the task of
representing the patient in partici-
pation in research between spouses
and parents at 8.0 (7.0–9.0), chil-
dren at 7.5 (6.0–9.0), siblings at 7.0
(5.5–7.0), and others at 6.0 (5.5–7.5)
(p= 0.02), conﬁdence level concern-
ing medical decisions were similar
for the different representatives.
The differences between the two
studies are remarkable. One vital
dissimilarity between our study and
the one by Ciroldi et al. was timing
of consent. Indeed, while Ciroldi et
al. obtained their data at the time of
discharge from the ICU, we acquired
data early after admission to the
ICU. It remains uncertain, however,
whether this really explains the dif-
ferences between the two studies.
Ciroldi et al. hypothesize that pa-
tients and surrogates may be less
inclined to give consent in a hypo-
thetical situation than in real life.
Although this may be the case for
France, our data at least suggest this
not to be the case for the Nether-
lands. Another difference between
France and the Netherlands appears
to speak against the suggestion that
formal designation of surrogates im-
proves the representation of patient’s
wishes: in contrast to France, where
10% of representatives are formal
designated surrogates, in the Nether-
lands only 0.5% of the patients in our
study had a legal representative.
The different results from these
two studies underline the importance
ofstudyingthis topicinabroadercon-
text: differences between countries
should be recognized when changing
legislation.
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